{
    "Symbol": "BNTX",
    "AssetType": "Common Stock",
    "Name": "BioNTech SE",
    "Description": "BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.",
    "CIK": "1776985",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "AN DER GOLDGRUBE 12, MAINZ, DE",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "19443073000",
    "EBITDA": "-166900000",
    "PERatio": "158.2",
    "PEGRatio": "0.0449",
    "BookValue": "84.0",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.51",
    "RevenuePerShareTTM": "11.37",
    "ProfitMargin": "0.0414",
    "OperatingMarginTTM": "-2.682",
    "ReturnOnAssetsTTM": "-0.0088",
    "ReturnOnEquityTTM": "0.0056",
    "RevenueTTM": "2729600000",
    "GrossProfitTTM": "16065200000",
    "DilutedEPSTTM": "0.51",
    "QuarterlyEarningsGrowthYOY": "-0.795",
    "QuarterlyRevenueGrowthYOY": "-0.853",
    "AnalystTargetPrice": "113.86",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "5",
    "AnalystRatingHold": "9",
    "AnalystRatingSell": "2",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "158.2",
    "ForwardPE": "7.04",
    "PriceToSalesRatioTTM": "5.46",
    "PriceToBookRatio": "0.958",
    "EVToRevenue": "0.871",
    "EVToEBITDA": "3.057",
    "Beta": "0.233",
    "52WeekHigh": "125.83",
    "52WeekLow": "78.02",
    "50DayMovingAverage": "89.01",
    "200DayMovingAverage": "93.92",
    "SharesOutstanding": "240990000",
    "DividendDate": "2022-06-17",
    "ExDividendDate": "2022-06-02"
}